BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2000
View Archived Issues
Zambon and Sheffield file for MSI-Albuterol approval via European centralized procedure
Read More
Novel therapeutic approaches for diabetic nephropathy explored
Read More
Incara advances research programs during first four months of the year
Read More
RxKinetix and Elan form joint venture for oral mucositis drug development
Read More
Interneuron highlights Q2 developments
Read More
Ciblex's CBX-10913 blocks inflammation in mice
Read More
Exelon gains Canadian approval as new treatment for Alzheimer's disease
Read More
Yale receives NIDA grant to advance Cantab's anticocaine vaccine
Read More
CV Therapeutics moves CVT-510 to phase III
Read More
EntreMed responds to premature disclosure of trial data
Read More
New inhibitor of ICAM-1/LFA-1-mediated cell adhesion produced by Streptomyces
Read More
Squalamine demonstrates preclinical activity in retinopathy
Read More
SuperGen anticancer compound subject of new CRADA
Read More
Pantoprazole now available for more uses
Read More
Lilly's Evista receives additional approval in E.U. for the treatment of osteoporosis
Read More
Pierre Fabre becomes Recordati's partner for lercanidipine in France
Read More
New treatment option for patients with atrial fibrillation/atrial flutter introduced in U.S.
Read More
First market launch for novel antiepileptic drug Keppra
Read More
Leflunomide analogue protects against renal allograft rejection in combination with ciclosporin
Read More
Cognetix and collaborators discover novel conopeptides interacting with voltage-gated K+ channels
Read More
Selective RXR agonists designed at Allergan particularly useful for skin-related diseases
Read More
Two new series of PDE5 inhibitors claimed by Pfizer
Read More
Imidazolones targeting Y5 receptors described by BMS as anorectic agents
Read More
Antisense oligonucleotides for modifying bcl-x expression in the Isis pipeline
Read More
Abbott continues to search for new ketolide antibacterial agents
Read More
FDA denies approval for Refludan in acute coronary syndrome
Read More
Major approval obtained for Mylotarg, the first antibody-targeted chemotherapy product
Read More
Clinical data support equivalence of Gengraf and Neoral; Gengraf approved by FDA
Read More
Transplant 2000 news: novel strategy for preventing chronic rejection in renal allograft recipients
Read More